How are cancer and connective tissue diseases related to sarcoidosis?

Current Opinion in Pulmonary Medicine

Volumn 21, Issue 5, 2015, Pages 517-524

  Chopra, Amit ^a   Judson, Marc A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Connective tissue disease; Diagnosis; Sarcoid like reactions; Sarcoidosis

Indexed keywords

CANCER RISK; CONNECTIVE TISSUE DISEASE; HUMAN; IMMUNOPATHOGENESIS; MALIGNANT NEOPLASTIC DISEASE; PATHOGENESIS; REVIEW; SARCOIDOSIS; SCLERODERMA; SKIN CANCER; COMPLICATION; CONNECTIVE TISSUE DISEASES; NEOPLASMS; RISK;

CONNECTIVE TISSUE DISEASES; HUMANS; NEOPLASMS; RISK; SARCOIDOSIS;

EID: 84942845592     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000186     Document Type: Review

References (81)

1. Judson MA. Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep 2014; 6:89.
2. Judson MA. The diagnosis of sarcoidosis. Clin Chest Med 2008; 29:415-427; viii.
3. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:149-173.
4. Lee NS, Barber L, Kanchwala A, et al. Low levels of NF-kappaB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol 2011; 18:223-234.
5. Drent M, Lower EE, De Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40:255-263.
6. Hoitsma E, Drent M, Verstraete E, et al. Abnormal warm and cold sensation thresholds suggestive of small-fibre neuropathy in sarcoidosis. Clin Neuro-physiol 2003; 114:2326-2333.
7. Bakkers M, Merkies IS, Lauria G, et al. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 2009; 73:1142-1148.
8. Marchell RM, Judson MA. Cutaneous sarcoidosis. Semin Respir Crit Care Med 2010; 31:442-451.
9. Padilla ML, Schilero GJ, Teirstein AS. Sarcoidosis and transplantation. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14:16-22.
10. Israel HL, Goldstein RA. Hepatic granulomatosis and sarcoidosis. Ann Intern Med 1973; 79:669-678.
11. Judson MA, Baughman RP. How many organs need to be involved to diagnose sarcoidosis?: an unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31:6-7.
12. Criado E, Sanchez M, Ramirez J, et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010; 30:1567-1586.
13. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889.
14. Brincker H. Sarcoid reactions and sarcoidosis in Hodgkin's disease and other malignant lymphomata. Br J Cancer 1972; 26:120-123.
15. Yamaguchi M, Odaka M, Hosoda Y, et al. Excess death of lung cancer among sarcoidosis patients. Sarcoidosis 1991; 8:51-55.
16. Kataoka M, Nakata Y, Hioka T, et al. [Malignancies in patients with sarcoi-dosis]. Nihon Kyobu Shikkan Gakkai zasshi 1992; 30:598-603.
17. Askling J, Grunewald J, Eklund A, et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999; 160:1668-1672.
18. Boffetta P, Rabkin CS, Gridley G. Acohort studyofcancer among sarcoidosis patients. Int J Cancer 2009; 124:2697-2700.
19. Ji J, Shu X, Li X, et al. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 2009; 20:1121-1126.
20. Kapoor S. Cutaneous and systemic malignancies in patients with sarcoidosis: a close association. Ann Acad Med Singapore 2009; 38:179.
21. Seersholm N, Vestbo J, Viskum K. Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax 1997; 52:892-894.
22. Shu X, Ji J, Sundquist K, et al. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964-2006. Ann Oncol 2011; 22:1427-1434.
23. Le Jeune I, Gribbin J, West J, et al. The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 2007; 101:2534-2540.
24. Romer FK, Hommelgaard P, Schou G. Sarcoidosis and cancer revisited: a long-term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J 1998; 12:906-912.
25. Brincker H. Coexistence of sarcoidosis and malignant disease: causality or coincidence? Sarcoidosis 1989; 6:31-43.
26. Brincker H. The sarcoidosis-lymphoma syndrome. Br J Cancer 1986; 54:467-473.
27. Sogaard KK, Svaerke C, Thomsen RW, Norgaard M. Sarcoidosis and subsequent cancer risk: a Danish nationwide cohort study. Eur Respir J 2015; 45:269-272.
28. Kristinsson SY, Landgren O, Samuelsson J, et al. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 2010; 95:1216-1220.
29. Mellemkjaer L, Pfeiffer RM, Engels EA, et al. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lympho-ma. Arthritis Rheum 2008; 58:657-666.
30. Landgren O, Engels EA, Pfeiffer RM, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst 2006; 98:1321-1330.
31. Blank N, Lorenz HM, Ho AD, Witzens-Harig M. Sarcoidosis and the occurrence of malignant diseases. Rheumatol Int 2014; 34:1433-1439.
32. Hemminki K, Liu XD, Ji JG, et al. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol 2012; 127:180-185.
33. Bonifazi M, Bravi F, Gasparini S, et al. Sarcoidosis and cancer risk: systematic review and meta-analysis of observational studies. Chest 2015; 147: 778-791.
34. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988; 43:516-524.
35. Urbankowski T, Knyziak-Medrzycka I, Domagala-Kulawik J, Chazan R. [Sarcoi-dosis and tobacco smoking-clinical picture, diagnostic tests results and bronch-oalveolar lavage fluid composition]. Pol Merkur Lekarski 2012; 32:298-301.
36. Peros-Golubicic T, Ljubic S. Cigarette smoking and sarcoidosis. Acta Med Croatica 1995; 49:187-193.
37. Gupta D, Singh AD, Agarwal R, et al. Is tobacco smoking protective for sarcoidosis? A case-control study from North India. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27:19-26.
38. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170:1324-1330.
39. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011; 306:1891-1901.
40. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296:2823-2831.
41. Carenco C, Faure S, Herrero A, et al. Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors. Liver Int 2015; 35:1748-1755.
42. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125:1747-1754.
43. Masunaga Y, Ohno K, Ogawa R, et al. Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease. Ann Pharmacother 2007; 41:21-28.
44. Salliot C, van der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis 2009; 68:1100-1104.
45. Lopez-Olivo MA, Tayar JH, Martinez-Lopez JA, et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA 2012; 308:898-908.
46. Cush JJ, Dao KH. Malignancy risks with biologic therapies. Rheum Dis Clin North Am 2012; 38:761-770.
47. Williams CJ, Peyrin-Biroulet L, Ford AC. Systematic review with meta-ana-lysis: malignancies with antitumour necrosis factor-alpha therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2014; 39:447-458.
48. Mathew S, Bauer KL, Fischoeder A, et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol 2008; 181:746-755.
49. Becker CD, Teirstein AS. Comment on 'the anergic state in sarcoidosis is associated with diminished dendritic cell function'. J Immunol 2009; 182:3943; author reply.
50. Miyara M, Amoura Z, Parizot C, et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203:359-370.
51. Zaba LC, Smith GP, Sanchez M, Prystowsky SD. Dendritic cells in the pathogenesis of sarcoidosis. Am J Respir Cell Mol Biol 2010; 42:32-39.
52. Tana C, Giamberardino MA, Di Gioacchino M, et al. Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth? Int J Immunopathol Pharmacol 2013; 26:305-313.
53. Allavena P, Germano G, Marchesi F, Mantovani A. Chemokines in cancer related inflammation. Exp Cell Res 2011; 317:664-673.
54. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008; 454:436-444.
55. Matsuda M, Sakurai K, Fushimi T, et al. Sarcoidosis with high serum levels of vascular endothelial growth factor (VEGF), showing RS3PE-like symptoms in extremities. Clin Rheumatol 2004; 23:246-248.
56. Sekiya M, Ohwada A, Miura K, et al. Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis. Lung 2003; 181:259-265.
57. Pabst S, Karpushova A, Diaz-Lacava A, et al. VEGF gene haplotypes are associated with sarcoidosis. Chest 2010; 137:156-163.
58. Tchernev G, Tana C, Schiavone C, et al. Sarcoidosis vs. sarcoid-like reactions: the two sides of the same coin? Wien Med Wochenschr 2014; 164:247-259.
59. Lequoy M, Coriat R, Rouquette A, et al. Sarcoidosis lung nodules in colorectal cancer follow-up: sarcoidosis or not? Am J Med 2013; 126:642-645.
60. Kumar S, Baghdadi S, Cale AR. Concurrence of sarcoidosis and lung cancer: a diagnostic dilemma. Thorax 2006; 61:1100.
61. Reich JM. Concurrent sarcoidosis and lung cancer. Chest 2009; 136:943; author reply 4.
62. Kobayashi N, Nakamura R, Kurishima K, et al. Sarcoidosis and lung cancer. Acta Med 2010; 53:115-118.
63. Mimura K, Mochizuki Y, Nakahara Y, et al. [A case of primary lung cancer with swollen mediastinal lymph nodes due to preexisting sarcoidosis]. Nihon Kokyuki Gakkai Zasshi 2011; 49:208-213.
64. Zivin S, David O, Lu Y. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT. Intern Med 2014; 53:2555-2556.
65. Shin HC, Choe JW, Ryu HS, et al. Sarcoidosis mimicking metastatic breast cancer in Korean woman with breast cancer. Breast J 2014; 20: 198-199.
66. Bush E, Lamonica D, O'Connor T. Sarcoidosis mimicking metastatic breast cancer. Breast J 2011; 17:533-535.
67. Akhtari M, Quesada JR, Schwartz MR, et al. Sarcoidosis presenting as metastatic lymphadenopathy in breast cancer. Clin Breast Cancer 2014; 14:e107-110.
68. Dietl J, Horny HP, Ruck P, Kaiserling E. Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells. Cancer 1993; 71:2562-2568.
69. Pickard WR, Clark AH, Abel BJ. Florid granulomatous reaction in a seminoma. Postgrad Med J 1983; 59:334-335.
70. Davanageri RS, Bannur HB, Mastiholimath RD, et al. Germ cell tumor of ovary with plenty of sarcoid like granulomas: a diagnosis on fine needle aspiration cytology. J Cytol 2012; 29:211-212.
71. Logan TF, Bensadoun ES. Increased disease activity in a patient with sarcoidosis after high dose interleukin 2 treatment for metastatic renal cancer. Thorax 2005; 60:610-611.
72. Yao M, Funk GF, Goldstein DP, et al. Benign lesions in cancer patients: Case 1. Sarcoidosis after chemoradiation for head and neck cancer. J Clin Oncol 2005; 23:640-641.
73. Sacchi S, Kantarjian H, O'Brien S, et al. Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia. J Clin Oncol 1995; 13:2401-2407.
74. Brincker H. Sarcoidosis and malignancy. Chest 1995; 108:1472-1474.
75. Brincker H. Interpretation of granulomatous lesions in malignancy. Acta Oncol 1992; 31:85-89.
76. Brincker H, Pedersen NT. Immunohistologic separation of B-cell-positive granulomas from B-cell-negative granulomas in paraffin-embedded tissues with special reference to tumor-related sarcoid reactions. APMIS 1991; 99:282-290.
77. Reich JM, Mullooly JP, Johnson RE. Linkage analysis of malignancy-associated sarcoidosis. Chest 1995; 107:605-613.
78. Chowdhury FU, Sheerin F, Bradley KM, Gleeson FV. Sarcoid-like reaction to malignancy on whole-body integrated (18)F-FDG PET/CT: prevalence and disease pattern. Clin Radiol 2009; 64:675-681.
79. Inoue K, Goto R, Shimomura H, Fukuda H. FDG-PET/CT of sarcoidosis and sarcoid reactions following antineoplastic treatment. Springerplus 2013; 2:113.
80. Judson MA, Shapiro L, Freitas S, et al. Concomitant sarcoidosis and a connective tissue disease: review of the clinical findings and postulations concerning their association. Respir Med 2013; 107:1453-1459.
81. Hemminki K, Li X, Sundquist J, Sundquist K. Familial associations of rheu matoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum 2009; 60:661-668.